These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 11304468)

  • 1. Nitric oxide differentially regulates induction of type II nitric oxide synthase in rat vascular smooth muscle cells versus macrophages.
    Zhang H; Snead C; Catravas JD
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):529-35. PubMed ID: 11304468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IkappaB.
    Chang K; Lee SJ; Cheong I; Billiar TR; Chung HT; Han JA; Kwon YG; Ha KS; Kim YM
    Exp Mol Med; 2004 Aug; 36(4):311-24. PubMed ID: 15365250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of lipopolysaccharide-mediated induction of nitric oxide synthase and inhibition of DNA synthesis in RAW 264.7 macrophages and rat aortic smooth muscle cells.
    Paul A; Bryant C; Lawson MF; Chilvers ER; Plevin R
    Br J Pharmacol; 1997 Apr; 120(8):1439-44. PubMed ID: 9113363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells.
    Teng X; Zhang H; Snead C; Catravas JD
    Gen Pharmacol; 2000 Jan; 34(1):9-16. PubMed ID: 10793263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells.
    Marczin N; Go CY; Papapetropoulos A; Catravas JD
    Br J Pharmacol; 1998 Mar; 123(5):1000-8. PubMed ID: 9535031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
    Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of tissue factor expression in smooth muscle cells with nitric oxide.
    Kibbe MR; Johnnides C; Gleixner S; Kovesdi I; Lizonova A; Zuckerbraun B; Billiar TR; Tzeng E; Muluk SC
    J Vasc Surg; 2003 Mar; 37(3):650-9. PubMed ID: 12618706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells.
    Zhou J; Struthers AD; Lyles GA
    Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells.
    Rikitake Y; Hirata K; Kawashima S; Akita H; Yokoyama M
    Atherosclerosis; 1998 Jan; 136(1):51-7. PubMed ID: 9544731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB mediates simultaneous induction of inducible nitric-oxide synthase and Up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages.
    Hammermann R; Dreissig MD; Mössner J; Fuhrmann M; Berrino L; Göthert M; Racké K
    Mol Pharmacol; 2000 Dec; 58(6):1294-302. PubMed ID: 11093766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Hirata Y
    J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells.
    Zhang H; Chen X; Teng X; Snead C; Catravas JD
    Biochem Pharmacol; 1998 Jun; 55(11):1873-80. PubMed ID: 9714306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species.
    Fries DM; Paxinou E; Themistocleous M; Swanberg E; Griendling KK; Salvemini D; Slot JW; Heijnen HF; Hazen SL; Ischiropoulos H
    J Biol Chem; 2003 Jun; 278(25):22901-7. PubMed ID: 12690103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells.
    Wong HR; Menendez IY
    Biochem Biophys Res Commun; 1999 Aug; 262(2):375-80. PubMed ID: 10462483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.
    Zhang H; Teng X; Snead C; Catravas JD
    Br J Pharmacol; 2000 May; 130(2):270-8. PubMed ID: 10807663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
    Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
    Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.
    Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y
    Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.